In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029

The U.S. in vitro diagnostics (IVD) market remains the largest and most influential in the world This multi-billion-dollar industry serves as the incubator for cutting-edge medical technologies, driving innovation and setting the benchmark for diagnostic standards worldwide. Yet, this dynamic market faces a period of transformation, balancing challenges such as cost pressures, regulatory changes, and the lingering impacts of COVID-19—all while adapting to a rapidly aging population and increasing demand for precision diagnostics.

Kalorama Information's fifth edition in the series, In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029, delivers a comprehensive analysis of the trends, technologies, and players driving this critical sector. With data-backed insights, this report is your definitive guide to understanding the complexities of the U.S. IVD market.

What’s in the Report

• Comprehensive Market Analysis: Gain detailed insights into key U.S. IVD segments, including:
  • Clinical Chemistry
  • Microbiology (Traditional) – Identification and Antibiotic Susceptibility Testing (ID/AST)
  • Microbiology – Molecular- Infectious Disease
  • Point-of-Care (POC) Tests – Diabetes
  • Point-of-Care (POC) Tests – All Other
  • Immunoassays – Infectious Disease (non-POC)
  • Immunoassays – Other
  • Molecular - Non-infectious Disease
  • Hematology
  • Coagulation (non-POC)
  • Histology
  • Blood Testing and Typing
  • Others
• Stay Ahead of the Curve: Understand how demographic shifts, technological advancements, and public health challenges are reshaping the market.
• Competitive Intelligence: Explore profiles of leading IVD companies, such as Roche Diagnostics, Abbott, Siemens Healthineers, and Thermo Fisher Scientific, and stay informed about their latest developments.
• Data-Driven Insights: With market data spanning 2024–2029, this report equips readers with the knowledge to identify growth opportunities and make informed decisions.

Report Highlights

• Extensive Market Coverage: Dive deep into U.S. IVD segments, from microbiology and hematology to histology and blood typing.
• Top Company Profiles: Learn about the strategies and innovations of 20+ key players, including emerging trends and M&A activities.
• Actionable Insights: Leverage the report's findings to assess the current standard of care, forecast future trends, and anticipate market penetration for new tests and technologies.